Alpha Q Advisors LLC Gilead Sciences, Inc. Transaction History

Alpha Q Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $89,689 - $109,374	-1,253 Reduced 18.46%	5,534 $405 Million
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $11,943 - $13,543	163 Added 2.46%	6,787 $550 Million
Q3 2023 Oct 27, 2023	SELL	$73.94 - $80.67 $32,829 - $35,817	-444 Reduced 6.28%	6,624 $496 Million
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $608 - $693	8 Added 0.11%	7,068 $545 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $18,631 - $21,227	-241 Reduced 3.3%	7,060 $586 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $454,998 - $653,220	7,301 New	7,301 $627 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alpha Q Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Q Advisors LLC with notifications on news.